Company intelligence / Profile preview
PHCANN International
Amsterdam, Netherlands
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
PHCANN International produces and distributes EU-GMP certified medical cannabis products, with ongoing expansion in product formats and European market penetration. Clinical evidence relies primarily on established cannabinoid science and real-world data, not proprietary clinical trials.[1][2][3]
- Therapeutic areas
- OtherNeurologyPsychiatry
- Modalities
- Plant-derived medicinePhytochemicalSmall molecule
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Tyson 2.0 (Mike Tyson brand partnership)
Beyond the preview
Go deeper on PHCANN International.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PHCANN International.